Revolution Medicines Appoints Lorence Kim, M.D., Accomplished Health Care Industry Leader, to Board of Directors
July 13, 2022 07:00 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., July 13, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...
Arthritis Foundation Adds Arthritis Challenge Experience to the 2022 California Coast Classic Bicycle Tour, Presented by Amgen
April 28, 2022 09:00 ET
|
The Arthritis Foundation’s California Coast Classic Bicycle Tour
LOS ANGELES, April 28, 2022 (GLOBE NEWSWIRE) -- Organizers of the 2022 California Coast Classic Bicycle Tour + Arthritis Challenge Experience presented by Amgen, today announced that 70 spaces...
Revolution Medicines Reports Third Quarter Financial Results and Update on Corporate Progress
November 10, 2021 16:05 ET
|
Revolution Medicines, Inc.
RAS(ON) Inhibitor Development Candidates Targeting KRASG12C and RASMULTI Progressing Toward the Clinic; Company Showed Additional Preclinical Data Supporting Benefits and Differentiation Company...
FIVE PRIME ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of FPRX and Encourages Investors to Contact the Firm
March 04, 2021 12:02 ET
|
Bragar Eagel & Squire
NEW YORK, March 04, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of...
Revolution Medicines Announces Dosing of First Patient in Phase 1b Combination Study of RMC-4630 and AMG 510
June 09, 2020 07:30 ET
|
Revolution Medicines, Inc.
Study Evaluates Combination Treatment with Investigational SHP2 and KRASG12C Inhibitors in Patients with KRASG12C Mutant Solid Tumors REDWOOD CITY, Calif., June 09, 2020 (GLOBE NEWSWIRE) --...
Toronto Innovation Acceleration Partners Announces Strategic Partnership with Amgen
September 09, 2019 07:00 ET
|
Toronto Innovation Acceleration Partners
Toronto, Ontario, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Toronto Innovation Acceleration Partners (TIAP – formerly MaRS Innovation), a leading member-based Canadian provider of venture builder expertise...
VBI Vaccines Appoints Dr. Vlad Popovic as Vice President of Clinical Development and Medical Affairs
April 17, 2019 08:00 ET
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., April 17, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...
Innovest Global Provides Acquisition Update: Authority National Supply Closing Rescheduled to First Week of November and Secured LOI for $12 Million Revenue and Profitable Acquisition in the Building Industry
October 26, 2018 09:28 ET
|
Innovest Global, Inc
CLEVELAND, Oct. 26, 2018 (GLOBE NEWSWIRE) -- Innovest Global Inc. (OTC Markets: IVST) (the “Company” or “Innovest”), a conglomerate with operations in commercial and industrial products and...
Innovest Global: Record Sales, Major Clients, Significant Growth Mark 1st Half 2018 Letter to Shareholders, Q2 Report
July 23, 2018 07:50 ET
|
Innovest Global, Inc
CLEVELAND, July 23, 2018 (GLOBE NEWSWIRE) -- Innovest Global Inc. (OTC Pink Current:IVST) (the “Company” or “Innovest”), posted Q2 financial reports this morning, and the following Shareholder...
INVESTORS SAY EXECUTIVE PAY PACKAGES AT PHARMA MAY INCENTIVIZE DRUG PRICING RISKS
December 13, 2017 13:13 ET
|
Azzad Funds
Falls Church, Dec. 13, 2017 (GLOBE NEWSWIRE) -- SOURCE - AZZAD ASSET MANAGEMENT Investors today announced they have filed resolutions at five major pharmaceutical companies asking for information...